Last viewed:
NEPH
Prices are updated after-hours
NEPH
|
$2.14
6.1K
|
Health Technology
(0.0% 1d)
(-1.8% 1m)
(51.2% 1y)
(0.0% 2d)
(2.4% 3d)
(1.9% 7d)
(-95.23%
volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 22,564,457
http://www.nephros.com
Sec
Filling
|
Patents
| 25 employees
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
renal
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-03-07
(Crawled : 21:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| -29.14%
| O: -2.98%
H: 2.05%
C: -7.85%
year
financial
results
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-02-29
(Crawled : 22:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| -32.28%
| O: 0.47%
H: 2.78%
C: -2.68%
conference
year
financial
results
Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer
Published: 2024-01-24
(Crawled : 13:00)
- globenewswire.com
RZLT
4
|
$2.9
1.4%
270K
|
Technology Services
| 180.39%
| O: 2.94%
H: 4.76%
C: 3.33%
NEPH
|
$2.14
6.1K
|
Health Technology
| -39.38%
| O: 0.0%
H: 3.12%
C: 0.57%
financial
Nephros Announces Results for Quarter Ended September 30, 2023
Published: 2023-11-08
(Crawled : 21:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| 6.63%
| O: -8.2%
H: 6.11%
C: 6.11%
results
Nephros Hires Judy Krandel as Chief Financial Officer
Published: 2023-11-01
(Crawled : 12:00)
- globenewswire.com
FNCTF
|
News
|
$11.16
130
|
Communications
| -8.15%
| O: -1.44%
H: 0.0%
C: -1.88%
XYF
|
News
|
$3.82
-1.61%
3.2K
|
Finance
| -3.48%
| O: -1.46%
H: 1.48%
C: -0.29%
NEPH
|
$2.14
6.1K
|
Health Technology
| 29.7%
| O: -3.02%
H: 7.49%
C: 6.89%
financial
Nephros Schedules Third Quarter 2023 Financial Results Conference Call
Published: 2023-10-25
(Crawled : 12:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| 29.7%
| O: 4.85%
H: 0.0%
C: -7.4%
conference
financial
results
Nephros Announces Results for Quarter Ended June 30, 2023
Published: 2023-08-09
(Crawled : 20:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| 52.86%
| O: 5.86%
H: 11.34%
C: 1.89%
results
Nephros Schedules Second Quarter 2023 Financial Results Conference Call
Published: 2023-07-26
(Crawled : 12:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| 58.52%
| O: 0.73%
H: 4.42%
C: 0.74%
conference
financial
results
Nephros Announces Results for Quarter Ended March 31, 2023
Published: 2023-05-10
(Crawled : 20:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| 46.58%
| O: 6.16%
H: 0.0%
C: -6.65%
results
Nephros Announces CEO Retirement and Succession Plan
Published: 2023-05-08
(Crawled : 12:00)
- globenewswire.com
NEPH
|
$2.14
6.1K
|
Health Technology
| 48.61%
| O: 2.08%
H: 6.8%
C: 1.36%
ceo
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001048462-24-000011
4
2024-03-14
2024-03-13
Buy
J
91463
98463
0001048462-24-000011
4
2024-03-14
2024-03-12
Buy
P
7000
7000